{"id":"W4410809403","doi":"10.1200/jco.2025.43.16_suppl.tps5111","title":"Phase 1, open-label, first-in-human study of ABBV-969, a dual variable antibody-drug conjugate, in patients with metastatic castration-resistant prostate cancer.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"AbbVie","keywords":"Medicine; Conjugate; Antibody-drug conjugate; Prostate cancer; Castration; Antibody; Orchiectomy; Prostate; Oncology; Cancer; Internal medicine; Monoclonal antibody; Immunology; Hormone","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001631846,0.00244419,0.001975454,0.0005725613,0.0006045538,0.001530323,0.001214489,0.001891517,0.007598157],"category_scores_gemma":[0.0009739983,0.001194589,0.001337035,0.0004738778,0.001190668,0.001392325,0.0004184569,0.004702854,0.00190881],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001514623,"about_ca_system_score_gemma":0.002154809,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001434277,"about_ca_topic_score_gemma":0.004670701,"domain_scores_codex":[0.9994265,0.0002522062,0.00001955967,0.000106922,0.00006655278,0.0001283261],"domain_scores_gemma":[0.999221,0.00009918079,0.00016804,0.00006265684,0.00006670301,0.0003824316],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.598693,0.2176343,0.005920461,0.001561657,0.001505729,0.0005190911,0.0004667605,0.003998631,0.06883194,0.0006208567,0.009043433,0.09120423],"study_design_scores_gemma":[0.323622,0.6553493,0.007527504,0.00004272315,0.0003404811,0.0005565895,0.00009393461,0.001082936,0.004779206,0.0003309225,0.006221009,0.00005343175],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9742503,0.004061796,0.001674364,0.0006738045,0.000298428,0.009440704,0.005116878,0.0003066086,0.00417698],"genre_scores_gemma":[0.9722441,0.003106305,0.003435143,0.001521598,0.0002253122,0.00556586,0.005774713,0.00009326219,0.008033795],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007598157,"threshold_uncertainty_score":0.0254184,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1171370828034375,"score_gpt":0.5319695346725988,"score_spread":0.4148324518691613,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}